Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINCRISTINE for Osteosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 45 adverse event reports in the FDA FAERS database where VINCRISTINE was used for Osteosarcoma.

Most Reported Side Effects for VINCRISTINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 8,676 12.0% 992 5,763
Off label use 6,562 9.0% 1,506 1,919
Disease progression 5,252 7.2% 1,243 678
Neutropenia 4,982 6.9% 806 1,982
Drug ineffective 4,084 5.6% 1,284 957
Pyrexia 3,460 4.8% 458 2,505
Product use in unapproved indication 3,073 4.2% 728 809
Thrombocytopenia 2,940 4.1% 534 1,108
Sepsis 2,791 3.9% 1,413 1,260
Anaemia 2,603 3.6% 412 1,238
Pneumonia 2,435 3.4% 865 1,353
Death 2,236 3.1% 2,236 235
Pancytopenia 2,180 3.0% 512 1,064
Nausea 1,908 2.6% 177 1,025
Infection 1,887 2.6% 819 566

Other Indications for VINCRISTINE

Diffuse large b-cell lymphoma (14,922) Acute lymphocytic leukaemia (9,875) B-cell lymphoma (4,346) Product used for unknown indication (3,760) Non-hodgkin's lymphoma (3,308) Chemotherapy (1,743) Hodgkin's disease (1,695) Lymphoma (1,452) Mantle cell lymphoma (1,361) Burkitt's lymphoma (1,275)

Other Drugs Used for Osteosarcoma

METHOTREXATE (1,267) DOXORUBICIN (1,135) CISPLATIN (975) IFOSFAMIDE (845) ETOPOSIDE (531) CARBOPLATIN (169) CABOZANTINIB S-MALATE (116) DOCETAXEL (99) CYCLOPHOSPHAMIDE (92) LENVATINIB (91)

Related Pages

VINCRISTINE Full Profile All Osteosarcoma Drugs VINCRISTINE Demographics VINCRISTINE Timeline